This study is a Clinical trial to assess the efficacy of nutrition support therapy of patients with liver failure. Patients were randomized to one of 2 groups to receive different nutrition and energy support treatment.
Patients with liver failure (defined by APASL) induced by any precipitating factors were randomized to two groups; a treatment group and a control group. Participants in treatment group were provided with a standard hospital diet that provided 25-30 kcal/kg/day . Patients in control group receive diet guide
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
100
patients were provided standard hospital diet that provided 25-30 kcal/kg/day
Mortality at 30 day
The percentage of death of liver failure patients at 4 weeks
Time frame: 4 weeks
liver transplant-free survival
survival rate on 4 weeks and 3 month
Time frame: 3month
Laboratory variables on serum biochemistry markers
Laboratory variables on serum lever of glutamic-pyruvic transaminase/glutamic oxalacetic transaminase/total bilirubin/ cholinesterase will be combined to report liver function
Time frame: 3month
Laboratory variables on fasting blood sugar
Laboratory variables on serum lever of fasting blood sugar
Time frame: 3month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.